Spots Global Cancer Trial Database for oral complications

Every month we try and update this database with for oral complications cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus	NCT02015559	Estrogen Recept... HER2-negative B... Oral Complicati... Progesterone Re... Recurrent Breas... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	mucoadhesive or... laboratory biom...	18 Years -	Jonsson Comprehensive Cancer Center
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer	NCT00003139	Head and Neck C... Oral Complicati...	pilocarpine hyd... Placebo	18 Years - 120 Years	Radiation Therapy Oncology Group
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer	NCT00004256	Head and Neck C... Oral Complicati... Radiation Toxic...	sargramostim quality-of-life... radiation thera...	20 Years - 80 Years	National Cancer Institute (NCI)
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy	NCT02123511	Mucositis Oral Complicati... Recurrent Adeno... Recurrent Basal... Recurrent Lymph... Recurrent Lymph... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Lymphoe... Stage I Lymphoe... Stage I Mucoepi... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage II Adenoi... Stage II Basal ... Stage II Lympho... Stage II Lympho... Stage II Mucoep... Stage II Saliva... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Verruc... Stage II Verruc... Stage III Adeno... Stage III Basal... Stage III Lymph... Stage III Lymph... Stage III Mucoe... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Lympho... Stage IV Squamo... Stage IVA Adeno... Stage IVA Basal... Stage IVA Lymph... Stage IVA Mucoe... Stage IVA Saliv... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVA Verru... Stage IVB Adeno... Stage IVB Basal... Stage IVB Lymph... Stage IVB Mucoe... Stage IVB Saliv... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Stage IVB Verru... Stage IVC Adeno... Stage IVC Basal... Stage IVC Lymph... Stage IVC Mucoe... Stage IVC Saliv... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Verru... Stage IVC Verru... Tongue Cancer	acetylcysteine placebo quality-of-life... questionnaire a...	18 Years -	Mayo Clinic
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx	NCT00004234	Head and Neck C... Oral Complicati...	management of t... radiation thera...	16 Years - 120 Years	Canadian Cancer Trials Group
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx	NCT00004234	Head and Neck C... Oral Complicati...	management of t... radiation thera...	16 Years - 120 Years	Canadian Cancer Trials Group
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus	NCT02015559	Estrogen Recept... HER2-negative B... Oral Complicati... Progesterone Re... Recurrent Breas... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	mucoadhesive or... laboratory biom...	18 Years -	Jonsson Comprehensive Cancer Center
Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation	NCT00003898	Oral Complicati... Unspecified Chi...	glutamine	1 Year - 21 Years	Roswell Park Cancer Institute
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer	NCT02273752	Estrogen Recept... Gastrinoma Glucagonoma HER2-negative B... Insulinoma Mucositis Oral Complicati... Pancreatic Poly... Progesterone Re... Recurrent Breas... Recurrent Islet... Recurrent Renal... Somatostatinoma Stage III Renal... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Renal ...	Everolimus	18 Years -	Emory University
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer	NCT00004061	Leukemia Lymphoma Oral Complicati...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide peripheral bloo... quality-of-life... radiation thera...	18 Years - 65 Years	National Cancer Institute (NCI)
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer	NCT00004061	Leukemia Lymphoma Oral Complicati...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide peripheral bloo... quality-of-life... radiation thera...	18 Years - 65 Years	National Cancer Institute (NCI)
Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer	NCT00003193	Head and Neck C... Oral Complicati...	amifostine trih... paclitaxel conventional su... radiation thera...	18 Years -	Massachusetts General Hospital
Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer	NCT00017511	Head and Neck C... Oral Complicati... Radiation Toxic...	cevimeline hydr...	18 Years -	Daiichi Sankyo
Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma	NCT00118339	Multiple Myelom... Plasma Cell Neo...	chemoprotection complementary o... management of t...	18 Years -	Fred Hutchinson Cancer Center
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer	NCT00008398	Head and Neck C... Oral Complicati... Radiation Toxic...	sargramostim quality-of-life... radiation thera...	-	Radiation Therapy Oncology Group
Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma	NCT00118339	Multiple Myelom... Plasma Cell Neo...	chemoprotection complementary o... management of t...	18 Years -	Fred Hutchinson Cancer Center
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer	NCT00004132	Drug/Agent Toxi... Leukemia Lymphoma Multiple Myelom... Oral Complicati... Radiation Toxic...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide quality-of-life... radiation thera...	12 Years - 65 Years	National Cancer Institute (NCI)
Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer	NCT00003193	Head and Neck C... Oral Complicati...	amifostine trih... paclitaxel conventional su... radiation thera...	18 Years -	Massachusetts General Hospital
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer	NCT00003139	Head and Neck C... Oral Complicati...	pilocarpine hyd... Placebo	18 Years - 120 Years	Radiation Therapy Oncology Group
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer	NCT00003313	Drug/Agent Toxi... Lung Cancer Oral Complicati... Radiation Toxic...	filgrastim amifostine trih... carboplatin paclitaxel radiation thera...	18 Years -	Radiation Therapy Oncology Group
Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01085617	Leukemia Mucositis Oral Complicati...	palifermin rituximab cyclophosphamid... cytarabine daunorubicin hy... etoposide fludarabine pho... imatinib mesyla... melphalan mercaptopurine methotrexate nelarabine pegaspargase vincristine sul... allogeneic hema... total-body irra...	25 Years - 65 Years	University College, London
Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer	NCT00003580	Drug/Agent Toxi... Head and Neck C... Oral Complicati... Radiation Toxic...	amifostine trih... cisplatin radiation thera...	18 Years -	National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx	NCT00025298	Drug/Agent Toxi... Head and Neck C... Oral Complicati... Radiation Toxic...	amifostine trih... carboplatin cisplatin paclitaxel radiation thera...	15 Years - 70 Years	European Organisation for Research and Treatment of Cancer - EORTC

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: